Prosecution Insights
Last updated: October 04, 2026

New&New Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

New&New Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's prosecution activity is limited to 1 distinct examiner and 1 distinct art unit, which simplifies the current administrative oversight of the portfolio. In the complex field of Biotechnology & Pharmaceuticals, having only 1 pending office action suggests a very targeted entry into the patent system. The alignment of the entire active portfolio under a single examiner means that any successful arguments made in the current action could set a favorable precedent for future filings.

BERRIOS, JENNIFER A is the busiest examiner for the company, overseeing the 1 pending office action. This single point of contact defines the current examination phase for the company's active patent applications. Since BERRIOS, JENNIFER A is the only examiner involved, the company's immediate patent goals are entirely dependent on the dialogue with this individual. Practitioners should focus on the specific examiner's past patterns to effectively resolve the 1 pending office action and move the portfolio toward issuance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BERRIOS, JENNIFER A 1 37.0% +49.8%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18501556 METHOD OF PREPARING MICROCURRENT-FORMING LIQUID CRYSTAL NANOEMULSION BERRIOS, JENNIFER A —

Top Art Units

Art UnitApps
1613 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18501556 METHOD OF PREPARING MICROCURRENT-FORMING LIQUID CRYSTAL NANOEMULSION BERRIOS, JENNIFER A 1613 §103 Final Rejection — Pending Nov 03, 2023

Managing New&New Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month